Skip to main content
Clinical Trials/NCT05561790
NCT05561790CompletedNot Applicable

Determination of Optimal Sleep Treatment Elements (The DOSE Project)

University of Aarhus1 site in 1 country169 target enrollmentStarted: September 6, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
169
Locations
1
Primary Endpoint
Insomnia severity post-intervention

Study Overview

Brief Summary

Previous research has shown the efficacy of (combinations of) individual components of cognitive behavioral therapy for insomnia (CBT-I), namely sleep hygiene education, sleep optimization, stimulus control therapy, deactivation/relaxation training, and cognitive therapy. However, their relative effects, i.e., their effects in direct comparison with each other, are yet to be assessed.

In this pilot study, a smartphone and web application developed to treat insomnia using these treatment components will be tested.

Two future studies will investigate the components' relative efficacy in order to identify the most effective component or combination of components for digitized treatment of chronic insomnia by means of the Multiphase Optimization Strategy (MOST), and verify this intervention's effect in a randomized controlled trial (RCT).

Detailed Description

As a pilot study for a Multiphase Optimization Strategy (MOST) study, the current study will assess the effects of a newly developed smartphone and web application for digitized cognitive behavioural therapy for insomnia (eCBT-I). All treatment components, i.e., sleep hygiene education, sleep optimization, stimulus control therapy, deactivation/relaxation training, and cognitive therapy, will be tested in order to receive feedback on the functioning of the application as well as to get an initial impression of possible treatment effects.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults (≥18 years)
  • •Individuals who report moderate-to-severe insomnia symptoms (a score ≥10 on the Insomnia Severity Index, ISI)
  • •Individuals with access to a smartphone or computer with internet connection
  • •Individuals who report sufficient technological proficiency (e.g., ability to download apps)

Exclusion Criteria

  • •Children (<18 years)
  • •Individuals who report mild or no clinically relevant insomnia symptoms (a score <10 on the ISI)
  • •Individuals who have a shift-work schedule or are on maternity/paternity leave, if this impacts their sleep quality or amount of sleep
  • •Individuals who are unable to read Danish
  • •Individuals who report severe physical or psychological comorbidity with known effects on sleep (e.g., psychosis, cardiovascular disease, cancer, COPD)
  • •Individuals who report other diagnosed sleep or circadian rhythm disorders (e.g., sleep apnea, narcolepsy)
  • •Individuals who have previously used the "Hvil®"-app, e.g., during the beta test phase

Arms & Interventions

Control

No Intervention

Waitlist control (sleep diary only); access to treatment after final measurement

Intervention

Experimental

Administration of sleep hygiene, sleep optimization, stimulus control therapy, deactivation/relaxation training, and cognitive therapy.

Intervention: eCBT-I (Behavioral)

Outcomes

Primary Outcomes

Insomnia severity post-intervention

Time Frame: 11 weeks after study entry (randomization)

Assessed with the Insomnia Severity Index (ISI), with scores ranging from 0 to 28, where higher scores indicate higher insomnia severity, and a score equal to or above 10 indicates clinical significance.

Secondary Outcomes

  • Sleep diary assessed sleep onset latency (SOL) at end of intervention(Approximately 10 weeks after study entry (randomization))
  • Sleep diary assessed nocturnal awakenings (NA) at end of intervention(Approximately 10 weeks after study entry (randomization))
  • Usability post-intervention(11 weeks after study entry (randomization))
  • Sleep diary assessed sleep efficiency (SE) at end of intervention(Approximately 10 weeks after study entry (randomization))
  • Daytime fatigue post-intervention(11 weeks after study entry (randomization))
  • Cognitions about sleep post-intervention(11 weeks after study entry (randomization))
  • Sleep diary assessed wake after sleep onset (WASO) at end of intervention(Approximately 10 weeks after study entry (randomization))
  • Sleep diary assessed total sleep time (TST) at end of intervention(Approximately 10 weeks after study entry (randomization))
  • Sleep diary assessed time in bed (TiB) at end of intervention(Approximately 10 weeks after study entry (randomization))
  • Psychological distress post-intervention(11 weeks after study entry (randomization))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials